(Q39003171)

8 September 2017

Frequent mono-allelic loss associated with deficient PTEN expression in imatinib-resistant gastrointestinal stromal tumors (English)

1 reference

8 September 2017

Giuseppe Floris

4

0 references

Agnieszka Wozniak

object named as

Agnieszka Wozniak

series ordinal

2

0 references

Piotr Rutkowski

object named as

Piotr Rutkowski

series ordinal

8

0 references

Vanessa Vanspauwen

series ordinal

5

object named as

Vanessa Vanspauwen

1 reference

8 September 2017

10

Maria Debiec-Rychter

1 reference

8 September 2017

7

Patrick Schöffski

1 reference

8 September 2017

9

Raf Sciot

1 reference

8 September 2017

6

Thomas Van Looy

1 reference

8 September 2017

1

Anna Quattrone

1 reference

8 September 2017

3

Barbara Dewaele

1 reference

8 September 2017

18 April 2014

1 reference

8 September 2017

1 reference

8 September 2017

27

1 reference

8 September 2017

11

1 reference

8 September 2017

1510-1520

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2014.53

8 September 2017

0 references

cites work

Endogenous viruses: insights into viral evolution and impact on host biology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

New insights into PTEN regulation mechanisms and its potential function in targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

Subtle variations in Pten dose determine cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

A potent combination of the novel PI3K Inhibitor, GDC-0941, with imatinib in gastrointestinal stromal tumor xenografts: long-lasting responses after treatment withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

The PTEN-PI3K pathway: of feedbacks and cross-talks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

Gastrointestinal stromal tumors: pathology and prognosis at different sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

The functions and regulation of the PTEN tumour suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

7 January 2021

Gastrointestinal stromal tumours: origin and molecular oncology.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

7 January 2021

A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

7 January 2021

Array CGH analysis in primary gastrointestinal stromal tumors: Cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.53

7 January 2021

10.1038/MODPATHOL.2014.53

Identifiers

DOI

1 reference

release_wxn2xwltbzhnto7i6i7liknua4

8 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wxn2xwltbzhnto7i6i7liknua4

24 November 2022

mapped directly with Wikidata item

PubMed ID

24743220

1 reference

PubMed ID

24743220